{
  "resourceType" : "Observation",
  "id" : "TransurethralEnucleationDiagnosticConclusionGrouper",
  "meta" : {
    "profile" : ["https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-diagnostic-conclusion-grouper|2026.0.0"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Observation TransurethralEnucleationDiagnosticConclusionGrouper</b></p><a name=\"TransurethralEnucleationDiagnosticConclusionGrouper\"> </a><a name=\"hcTransurethralEnucleationDiagnosticConclusionGrouper\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.patho@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-diagnostic-conclusion-grouper\">MII PR Patho Diagnostic Conclusion Grouperversion: null2026.0.0)</a></p></div><p><b>basedOn</b>: <a href=\"ServiceRequest-TransurethralEnucleationReportRequest.html\">ServiceRequest Simple prostatectomy (procedure)</a></p><p><b>status</b>: Final</p><p><b>category</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}\">Laboratory</span></p><p><b>code</b>: <span title=\"Codes:{http://loinc.org 22637-3}\">Pathology report final diagnosis Narrative</span></p><p><b>subject</b>: <a href=\"Patient-Patient3.html\">Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)</a></p><p><b>effective</b>: 2024-05-12</p><p><b>performer</b>: <a href=\"Practitioner-PathologistPractitioner.html\">Practitioner Maria Schneider </a></p><p><b>note</b>: By Practitioner/PathologistPractitioner @2024-05-12</p><blockquote><div><p>Zusammenfassung: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) mit invasiven kribriformen Anteilen und intraduktaler Karzinomkomponente. Gleason-Score 4+5=9, ISUP-Gradgruppe 5 (WHO 2016). Prozentualer Anteil Gleasonmuster 4 und 5: 90%. Ausgedehnte Tumorinfiltration, ca. 60% des Prostatagewebes befallen. Extraprostatische Ausbreitung nachgewiesen. Samenblaseninfiltration nachgewiesen. Lymphovaskuläre Invasion nachgewiesen. Perineurale Infiltration nachgewiesen. Empfehlung: Staging-Untersuchungen und interdisziplinäre Tumorkonferenz.</p>\n</div></blockquote><p><b>hasMember</b>: </p><ul><li><a href=\"Observation-TransurethralEnucleationHistologicalTypeICDO3.html\">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href=\"Observation-TransurethralEnucleationMorphologyFreeText.html\">Observation Histology type in Cancer specimen Narrative</a></li><li><a href=\"Observation-TransurethralEnucleationPrimaryGleasonPattern.html\">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href=\"Observation-TransurethralEnucleationSecondaryGleasonPattern.html\">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href=\"Observation-TransurethralEnucleationGleasonScoreTotal.html\">Observation Gleason score in Specimen Qualitative</a></li><li><a href=\"Observation-TransurethralEnucleationPercentageGleason45.html\">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area</a></li><li><a href=\"Observation-TransurethralEnucleationGradingGroupISUP.html\">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href=\"Observation-TransurethralEnucleationIntraductalCarcinoma.html\">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href=\"Observation-TransurethralEnucleationInvasiveCribriformCarcinoma.html\">Observation Invasive cribriform carcinoma (morphologic abnormality)</a></li><li><a href=\"Observation-TransurethralEnucleationProstaticTissueInvolved.html\">Observation Tissue cores.positive.carcinoma in Tissue core</a></li><li><a href=\"Observation-TransurethralEnucleationExtraprostaticExtension.html\">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href=\"Observation-TransurethralEnucleationSeminalVesicleInvasion.html\">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href=\"Observation-TransurethralEnucleationLymphovascularInvasion.html\">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href=\"Observation-TransurethralEnucleationPerineuralInfiltration.html\">Observation Perineural invasion [Presence] in Cancer specimen</a></li></ul><p><b>derivedFrom</b>: <a href=\"QuestionnaireResponse-QuestionnaireResponseTransurethralEnucleation.html\">Response to Questionnaire 'https://art-decor.org/fhir/Questionnaire/2.16.840.1.113883.3.1937.777.18.27.20--20250115134435' about '-&gt;Klaus Becker  Male, DoB: 1958-11-10 ( http://example.hospital.de/patient-ids#PAT-2024-003)'</a></p></div>"
  },
  "basedOn" : [{
    "reference" : "ServiceRequest/TransurethralEnucleationReportRequest"
  }],
  "status" : "final",
  "category" : [{
    "coding" : [{
      "system" : "http://terminology.hl7.org/CodeSystem/observation-category",
      "code" : "laboratory"
    }]
  }],
  "code" : {
    "coding" : [{
      "system" : "http://loinc.org",
      "code" : "22637-3"
    }]
  },
  "subject" : {
    "reference" : "Patient/Patient3"
  },
  "effectiveDateTime" : "2024-05-12",
  "performer" : [{
    "reference" : "Practitioner/PathologistPractitioner"
  }],
  "note" : [{
    "authorReference" : {
      "reference" : "Practitioner/PathologistPractitioner"
    },
    "time" : "2024-05-12",
    "text" : "Zusammenfassung: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3) mit invasiven kribriformen Anteilen und intraduktaler Karzinomkomponente. Gleason-Score 4+5=9, ISUP-Gradgruppe 5 (WHO 2016). Prozentualer Anteil Gleasonmuster 4 und 5: 90%. Ausgedehnte Tumorinfiltration, ca. 60% des Prostatagewebes befallen. Extraprostatische Ausbreitung nachgewiesen. Samenblaseninfiltration nachgewiesen. Lymphovaskuläre Invasion nachgewiesen. Perineurale Infiltration nachgewiesen. Empfehlung: Staging-Untersuchungen und interdisziplinäre Tumorkonferenz."
  }],
  "hasMember" : [{
    "reference" : "Observation/TransurethralEnucleationHistologicalTypeICDO3"
  },
  {
    "reference" : "Observation/TransurethralEnucleationMorphologyFreeText"
  },
  {
    "reference" : "Observation/TransurethralEnucleationPrimaryGleasonPattern"
  },
  {
    "reference" : "Observation/TransurethralEnucleationSecondaryGleasonPattern"
  },
  {
    "reference" : "Observation/TransurethralEnucleationGleasonScoreTotal"
  },
  {
    "reference" : "Observation/TransurethralEnucleationPercentageGleason45"
  },
  {
    "reference" : "Observation/TransurethralEnucleationGradingGroupISUP"
  },
  {
    "reference" : "Observation/TransurethralEnucleationIntraductalCarcinoma"
  },
  {
    "reference" : "Observation/TransurethralEnucleationInvasiveCribriformCarcinoma"
  },
  {
    "reference" : "Observation/TransurethralEnucleationProstaticTissueInvolved"
  },
  {
    "reference" : "Observation/TransurethralEnucleationExtraprostaticExtension"
  },
  {
    "reference" : "Observation/TransurethralEnucleationSeminalVesicleInvasion"
  },
  {
    "reference" : "Observation/TransurethralEnucleationLymphovascularInvasion"
  },
  {
    "reference" : "Observation/TransurethralEnucleationPerineuralInfiltration"
  }],
  "derivedFrom" : [{
    "reference" : "QuestionnaireResponse/QuestionnaireResponseTransurethralEnucleation"
  }]
}